Ciplar-LA 40mg 15 Tablets

Babies: It is not applicable for babies. Lactating mother: It is safe during breastfeeding.
Limited human studies suggest that the drug does not represent a significant risk to the baby. Pregnancy: It is unsafe to use this medicine during pregnancy. Limited human studies have shown harmful effects on the developing baby.
Seek doctor advice before using this medication. Driving: Ciplar tablets may cause side effects that could affect your ability to drive. Alcohol: It is unsafe to consume alcohol with ciplar tablets. Kidney: It is safe to use in patients with kidney disease. Liver: Ciplar tablets should use with caution in patients with kidney disease.
Dosage adjustment is needed. Seek doctor advice before using this medication..

Tiredness Weakness Raynaud phenomenon Irregular heartbeat Nausea Vomiting Diarrhea.

Ciplar tablet is a beta-blocker. It works by decreasing the heart rate, myocardial contractility, myocardial oxygen demand, and blood pressure..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• It is not the first-choice treatment for high blood pressure according to the latest guidelines • It may hide the symptoms of low blood sugar if you have diabetes check regular blood sugar levels • Use caution while driving or doing anything that requires concentration as ciplar tablets can cause dizziness and sleepiness • Inform your doctor if you experience swelling around your legs or ankles, sudden weight gain and sudden shortness of breath • Do not stop taking the medication suddenly without talking to your doctor.

Serious • Ciplar + Abametapir: Concurrent use of both drugs leads to increase the level or effect of propranolol by affecting hepatic enzyme cyp1a2 metabolism • Ciplar +Acebutolol: Concurrent use of both drugs leads to increase anti-hypertensive channel blocking • Ciplar +Atenolol: Concurrent use of both drugs leads to increase anti-hypertensive channel blocking • Ciplar + Bosutinib: Concurrent use of both drugs leads to increases levels of bosutinib by p-glycoprotein (mdr1) efflux transporter Monitor closely • Ciplar +Abiraterone: Concurrent use of both drugs leads to increases levels of propranolol by affecting hepatic enzyme cyp2d6 metabolism. • Ciplar + Antipyrine: Concurrent use of both drugs leads to an increased levels of antipyrine by decreasing metabolism.